6-hydroxydopamine-induced p38 activation in rat nigral dopaminergic neurons is reduced by treatment with a novel phospholipid-based drug formulation.
- Suzanne Crotty (Speaker)
- Patrick Fitzgerald (Speaker)
- D. M. Harris (Speaker)
- A. Fisher (Speaker)
- Arkady Mandel (Speaker)
- Anthony E. Bolton (Speaker)
- Sullivan, A. (Speaker)
- Nolan, Y. (Speaker)
Activity: Talk or presentation › Invited talk